Skip to content Skip to sidebar Skip to footer
New evidence shows long COVID’s toll on health across all U.S. states

New evidence shows long COVID’s toll on health across all U.S. states

Lingering post-COVID symptoms are more than a nuisance, they’re independently linked to poorer physical, mental, and daily functioning across all U.S. states, highlighting urgent needs for targeted care and recovery strategies. Study: The health-related quality of life among survivors with post-COVID conditions in the United States. Image Credit: p.ill.i / Shutterstock In…

Read more

Nirsevimab slashes RSV hospitalizations in infants by 78% in real-world study

Nirsevimab slashes RSV hospitalizations in infants by 78% in real-world study

Real-world data from Madrid hospitals show dramatic declines in infant ICU stays, hospital days, and RSV-related admissions after nirsevimab immunization campaign. Study:  Impact of Nirsevimab on RSV and Non-RSV Severe Respiratory Infections in Hospitalized Infants . Image Credit: Gorodenkoff / Shutterstock.com A recent Influenza and Other Respiratory Viruses study…

Read more

Scientists use AI to build mutation-proof antibodies for SARS-CoV-2

Scientists use AI to build mutation-proof antibodies for SARS-CoV-2

Scientists harnessed AI to create mutation-resistant antibodies that outperformed conventional drug design, offering a powerful new tool against fast-evolving viruses like SARS-CoV-2. Study: AI designed, mutation resistant broad neutralizing antibodies against multiple SARS-CoV-2 strains. Image Credit: Lightspring / Shutterstock In a recent study in the journal Scientific Reports, researchers tested and leveraged…

Read more

HHS and NIH announce the development of next-generation, universal vaccine platform

HHS and NIH announce the development of next-generation, universal vaccine platform

Colorized transmission electron micrograph of influenza A/H1N1 virus particles. The U.S. Department of Health and Human Services (HHS) and the National Institutes for Health (NIH) today announced the development of the next-generation, universal vaccine platform, Generation Gold Standard, using a beta-propiolactone (BPL)-inactivated, whole-virus platform. This initiative represents a decisive shift toward transparency, effectiveness, and comprehensive…

Read more

the Kick-ass Multipurpose WordPress Theme

© 2025 Kicker. All Rights Reserved.